Recall one batch of DoxyPure 100MG Inj
2026-02-05
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer DoxyPure 100MG Inj. Doxycycline Not registered K10623024 Akumentis Healthcare Ltd
التصنيف
التاريخ
2025-08-07
اسم المستحضر
DoxyPure 100MG Inj
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
The Saudi Food and Drug Authority (SFDA) has issued a recall of one batch of DoxyPure 100MG Inj. due to the product incompliance with the requirements of the executive regulations for the Pharmaceutical establishments system.
التوصيات
For healthcare professionals: Stop dispensing the affected batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batch, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.